Merritt H. Stiles, M.D.
JAMA. 1941;117(16):1378. doi:10.1001/jama.1941.02820420070031.
Text Size: A A A
Published online


To the Editor:—  In their tabulation of the toxic manifestations of sulfanilamide, sulfapyridine and sulfathiazole (The Journal, September 6, p. 850) Wein and Lieberthal state that symptoms of the gastrointestinal tract other than nausea and vomiting have not been reported following the administration of sulfathiazole. I should like to correct this statement by calling attention to a report published in the Pennsylvania Medical Journal in April 1941 (Hypersensitivity to Small Doses of Sulfathiazole). In 1 of the 4 cases reported the administration of moderate quantities of sulfathiazole was followed by active nausea, vomiting, fever and diarrhea. At a later date the same symptoms developed following the administration of a single tablet of the drug. Since the publication of this report I have encountered another case in which, as recently as two weeks previously, sulfathiazole had been given without causing a disturbance but in which nausea, vomiting and diarrhea developed in


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.